(Q44886865)

English

First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial

scientific article

Statements

First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial (English)
0 references
0 references
0 references
0 references
0 references
Giovenzio Genestreti
Rafal Wierzbicki
Raffaella Felletti
Ferdinando Riccardi
Gianfranco Mancuso
Francesco Perrone

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit